These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19481913)

  • 1. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
    Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Bouslama A
    Metab Syndr Relat Disord; 2011 Dec; 9(6):419-26. PubMed ID: 21870907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T45G and G276T adiponectin gene polymorphisms in primary aldosteronism and healthy controls in an East Slovak population.
    Jochmanová I; Habalová V; Wagnerová H; Galovičová A; Lazúrová I
    Physiol Res; 2013; 62(4):413-20. PubMed ID: 23590605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin.
    Jang Y; Lee JH; Kim OY; Koh SJ; Chae JS; Woo JH; Cho H; Lee JE; Ordovas JM
    Metabolism; 2006 Jan; 55(1):59-66. PubMed ID: 16324920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women.
    Jang Y; Chae JS; Koh SJ; Hyun YJ; Kim JY; Jeong YJ; Park S; Ahn CM; Lee JH
    Clin Chim Acta; 2008 May; 391(1-2):85-90. PubMed ID: 18328815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T; Yakout S; Vinodson B; Sabico S
    Gene; 2012 Feb; 493(1):142-7. PubMed ID: 22155316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
    Grigorescu M; Radu C; Crişan D; Grigorescu MD; Serban A; Neculoiu D; Rusu M; Acalovschi M
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):147-54. PubMed ID: 18568135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The - 11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects.
    Goyenechea E; Collins LJ; Parra D; Abete I; Crujeiras AB; O'Dell SD; Martínez JA
    Horm Metab Res; 2009 Jan; 41(1):55-61. PubMed ID: 18949681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population.
    Lee YY; Lee NS; Cho YM; Moon MK; Jung HS; Park YJ; Park HJ; Youn BS; Lee HK; Park KS; Shin HD
    Diabet Med; 2005 May; 22(5):569-75. PubMed ID: 15842511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F; Ronconi V; di Tizio V; Boscaro M; Giacchetti G
    Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].
    Deng YJ; Zhang SL; Liu PM; Mai LF; Tang JY; Yan L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):743-749. PubMed ID: 27667270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.